October 25, 2016 6:40 AM ET


Company Overview of Critical Biologics Corporation

Executive Profile

James W. Fordyce

Co-Founder and Chairman, Critical Biologics Corporation
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 6 different industries.

See Board Relationships


Mr. James W. Fordyce, also known as Jim is a Managing Partner at MEDNA Partners LLC. Mr. Fordyce serves as Chief Financial Officer and Executive Vice President of Lotus Tissue Repair, Inc. He is a General Partner of Prince Venture Partners I, LP. Mr. Fordyce serves as an Advisor at Darwin Ventures, LLC. He is Owner and General Partner of p-Value Capital. He Co-founded Critical Biologics Corporation in 2004. Mr. Fordyce has over 25 years of private equity investment experience ...

Corporate Headquarters

One Mifflin Place
Cambridge, Massachusetts 02138

United States

Phone: 908-439-9768
Fax: 908-439-9768

Board Members Memberships

Chairman Emeritus
Co-Founder and Chairman
Chairman, Executive Vice President and Chief Financial officer
Executive Director


MBA 1970
Harvard Business School
Unknown/Other Education 1964
University of Pennsylvania
Unknown/Other Education 1967
Magdalen College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Critical Biologics Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.